Human MST1 Knockdown Cell Line - HEK293

Mammalian Sterile 20-like kinase 1 (MST1), officially designated in human genetics as Serine/threonine-protein kinase 4 (STK4), is a highly conserved, ubiquitously expressed kinase that serves as a central regulatory node within the Hippo tumor suppressor signaling pathway. Biologically, MST1 plays a pivotal role in maintaining tissue homeostasis by strictly regulating organ size, cellular proliferation, and apoptosis. Upon activation by upstream mechanical stress or biochemical signals, MST1 dimerizes and autophosphorylates. It then directly phosphorylates and activates the downstream kinases LATS1 and LATS2. These activated LATS kinases subsequently phosphorylate the transcriptional co-activators YAP and TAZ, leading to their cytoplasmic sequestration and ubiquitin-mediated proteasomal degradation. When MST1 is inhibited or genetically depleted, unphosphorylated YAP and TAZ freely translocate into the nucleus, complex with TEAD transcription factors, and drive the expression of genes associated with aggressive cellular survival and proliferation. Due to this fundamental regulatory function, the loss or dysregulation of MST1 is frequently linked to tumorigenesis, primary immunodeficiencies, and severe autoimmune conditions.

The Human MST1 Knockdown Cell Line - HEK293 is a precisely engineered in vitro model built upon the extensively characterized Human Embryonic Kidney 293 lineage. By utilizing advanced genetic suppression techniques, this cell line is designed to exhibit a constitutive, highly significant reduction in endogenous MST1 protein expression. This specialized genetic background makes the cell line an indispensable tool for molecular biologists investigating the complex regulatory dynamics of the Hippo signaling cascade. Because the knockdown of MST1 artificially mimics the loss of tumor suppressor function, thereby promoting constitutive YAP/TAZ nuclear translocation, this model is heavily utilized in oncological research to study mechanisms of apoptosis resistance and cellular transformation. In standard laboratory environments, this stable cell line provides a highly reproducible platform for the targeted screening of novel pharmacological agents designed to modulate downstream Hippo pathway effectors. By eliminating the batch-to-batch variability and temporal limitations inherently associated with transient RNA interference protocols, this stable knockdown model significantly accelerates reliable downstream analytical workflows, including Western blotting, co-immunoprecipitation, and transcriptional reporter assays.